Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Functional Neurology|February 24, 2001
Rational migraine management: optimising treatment with the triptansD S MillsonCephalalgia : an International Journal of Headache|December 17, 1997
Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on > 3000 subjects treated with zolmitriptanJ G Edmeads, D S MillsonExpert Opinion on Pharmacotherapy|March 16, 2001
Migraine pharmacotherapy with oral triptans: a rational approach to clinical managementD S Millson, S J Tepper, A M RapoportCephalalgia : an International Journal of Headache|August 22, 2006
The natural history of headache: predictors of onset and recoveryH F Boardman, E Thomas, D S Millson, et al.Cephalalgia : an International Journal of Headache|February 27, 2003
Epidemiology of headache in an English districtH F Boardman, E Thomas, P R Croft, et al.The Annals of Pharmacotherapy|August 4, 2001
Upper gastroduodenal ulceration in arthritis patients treated with celecoxibD M Ashcroft, S R Chapman, W K Clark, et al.Cephalalgia : an International Journal of Headache|August 19, 2004
Advice and care for headaches: who seeks it, who gives it?E Thomas, H F Boardman, H Ogden, et al.British Journal of Clinical Pharmacology|October 1, 1991
The effects of a 5-HT2 receptor antagonist (ICI 169,369) on changes in waking EEG, pupillary responses and state of arousal in human volunteersD S Millson, S J Haworth, A Rushton, et al.European Journal of Neurology|May 1, 2001
Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international studyK Gruffyd-Jones, B Kies, A Middleton, et al.British Journal of Clinical Pharmacology|March 1, 1992
The effects of a selective 5-HT2 receptor antagonist (ICI 170,809) on platelet aggregation and pupillary responses in healthy volunteersD S Millson, C L Jessup, A Swaisland, et al.Pageof 2